Major Cutaneous Abscess
1 clinical trials · Condition
◉ Watch Major Cutaneous Abscess
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study (NCT01519778) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-02-15 |
Track Major Cutaneous Abscess automatically
Every clearance here is in the API, with alerts when new ones post.